MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.

Volume: 22, Issue: 5, Pages: 1342 - 1350
Published: Mar 1, 2018
Abstract
Drug resistance has become an important factor that threatens the survival and prognosis of patients with breast cancer, especially in patients with advanced breast cancer. Several microRNAs have been proved to participate in the resistant process; however, the role of miR-574 in doxorubicin (Dox) resistant breast cancer is still unclear.Quantitative Real-time poly chain reaction (qRT-PCR) was employed to detect the expression level of miR-574...
Paper Details
Title
MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Published Date
Mar 1, 2018
Journal
Volume
22
Issue
5
Pages
1342 - 1350
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.